Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease.
The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge.
Researchers have shown how cholesterol – a molecule normally linked with cardiovascular diseases – may also play an important role in the onset and progression of Alzheimer’s disease.
‘Women scientists have built our world. It’s time to invest in them’ – The Cambridge women campaigning for gender equality in science11 Feb 2018
“I was taught that the way of progress is neither swift nor easy”.
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer’s disease, and stop their production.
Researchers have identified how alpha-synuclein, the protein associated with Parkinson’s Disease, enables communication between neurons in the brain, offering important clues about what may be happening to patients when the protein malfunctions.
Tiny changes in Parkinson’s protein can have “dramatic” impact on processes that lead to the disease30 Aug 2016
Specific mutations in the protein associated with Parkinson’s Disease, in which just one of its 140 building blocks is altered, can make a dramatic difference to processes which may lead to the condition’s onset, researchers have found.
A specific gene expression pattern maps out which parts of the brain are most vulnerable to Alzheimer’s disease, decades before symptoms appear, and helps define the molecular origins of the disease.